Published on Monday October 01, 2018
Smooth has started to work on the following projects:
- Our company launches a phase II trial in AML for an international Sponsor.
- Smooth prepares to launch a bioequivalence trial in arthritis for a global pharmaceutical company.
- Our company is singing an agreement for a phase I clinical trial in stress disorder for a Russian company.
We reached important milestones in the following projects:
- Smooth clinical team received an approval for conduct of a trial of an innovative orphan drug in ALD.
- Our clinical team accomplished enrolment of patients in two phase III trials for a Russian and European Sponsors.
In the nearest future Smooth Corporate development team will attend:
- Outsourcing in Clinical Trials, Mid-Atlantic, October 2-4, Silver Spring Maryland, USA.